Author:
Lai Yaoliang,Liang Xiao,Fan Heng,Liu Yujin,Zheng Liang,Lu Weimin,Sun Yuling,Huang Dawei,Liu Xingxing,Zhang Lijian,Zuo Dongmei,Shou Zhexing,Tang Qing,Wang Yuanyuan,Li Zhen,Jiang Zhengyan,Zang Shuo,Huang Huisuo,Tang Zongxiang,Li Qian,Xiao Jun
Subject
Advanced and Specialized Nursing,Complementary and alternative medicine,Complementary and Manual Therapy
Reference44 articles.
1. A randomised controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome;Camilleri;Arch Intern Med,2001
2. Torborg L. Mayo Clinic Q and A: for most diagnosed with it, IBS is a chronic, lifelong condition; 2015. 〈https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-q-and-a-for-most-diagnosed-with-it-ibs-is-a-chronic-lifelong-condition/〉. [Accessed 20 April 2021].
3. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact;Hungin;Aliment Pharm Ther,2005
4. Quigley E, Fried M, Gwee K, Olano C, Guarner F, Khalif I, et al. Irritable bowel syndrome: a global perspective. World Gastroenterology Organisation Global Guideline; 2009. Page 3. 〈https://www.worldgastroenterology.org/guidelines/global-guidelines/irritable-bowel-syndrome-ibs/irritable-bowel-syndrome-ibs-english〉. [Accessed 20 April 2021].
5. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study;Paré;Clin Ther,2006